|9 Months Ended|
Sep. 30, 2022
In January 2021, the Company’s board of directors adopted the Volcon, Inc. 2021 Stock Plan, (the “2021 Plan”). The 2021 Plan is a stock-based compensation plan that provides for discretionary grants of stock options, stock awards, and restricted stock unit awards to employees, members of the board of directors and consultants (including restricted stock units issued prior to the adoption of the plan as further discussed below). The Company initially reserved a total ofshares of the Company’s common stock for issuance under the 2021 Plan. On July 26, 2022, the Company’s stockholders approved an increase of shares of the Company’s common stock for issuance under the 2021 plan, which may be adjusted for changes in capitalization and certain corporate transactions. To the extent that an award, if forfeitable, expires, terminates or lapses, or an award is otherwise settled in cash without the delivery of shares of common stock to the participant, then any unpaid shares subject to the award will be available for future grant or issuance under the 2021 Plan. Shares available for issuance under the 2021 Plan as of September 30, 2022, were shares. Awards vest according to each agreement and as long as the employee remains employed with the Company or the consultant continues to provide services in accordance with the terms of the agreement.
Restricted Stock Units
The following is the restricted stock unit activity for the nine months ended September 30, 2022:
In January 2022, the Company modified the vesting terms of was extended and these additional RSUs would also vest as of May 15, 2022. The Company recorded additional expenses of $1,126,250 during the nine months ended September 30, 2022, related to these modifications. The remaining shares that were vested as of December 31, 2021 were issued in January 2022. In January 2022, the Company granted RSUs that vested over 3 months (vesting began in December 2021), to a consultant.RSUs that had vested as of December 31, 2021 to extend the vesting through May 15, 2022. The Company granted an additional RSUs to the holders of these RSUs that vesting
The Company recognized expenses for RSUs of $ (including the amounts noted above), for the three and nine months ended September 30, 2022, respectively, and $( and $ ) and $ for the three and nine months ended September 30, 2021, respectively. The Company expects to recognize additional compensation expenses of $ related to RSUs assuming all awards outstanding at September 30, 2022 will vest.
In January 2021, the board of directors authorized 250,000 common shares to be reserved under the 2021 Plan for issuance to employees upon achieving multiple Company performance milestones. The allocation of the number of shares to be awarded was to be determined upon achievement of all the milestones. In July 2021, the Compensation Committee of the board of directors approved a grant of shares since some of the performance milestones were met. The Company recognized share-based compensation expenses of $ related to the grant of these shares.
The remainingshares not awarded in July 2021 were available for issuance to employees as of December 31, 2021 based upon achieving multiple Company performance milestones for the second half of 2021. On March 1, 2022, the Compensation Committee of the board of directors approved a grant of 44,623 shares for the achievement of some of the Company’s performance milestones, and the Company recognized share-based compensation expenses of $82,050 related to the grant of these shares in the quarter ended March 31, 2022. Certain individuals whose employment terminated subsequent to December 31, 2021 forfeited their share grants totaling shares and such shares are available for future issuance under the 2021 Plan.
The following summarizes activity relating to common stock options to employees and consultants for services during the nine months ended September 30, 2022:
On September 14, 2022, the Company grantedstock options to employees, excluding Company officers, of which 50% of the options will vest on March 15, 2023 and the remaining 50% will vest on September 14, 2023 so long as employment continues as of each applicable vesting date. The remaining grants during 2022 primarily represent options granted to new employees with vesting terms primarily over three years, one third on the employees’ employment anniversary date.
The Company valued the options using an estimated fair value of the shares of common stock between $$ respectively, and for the three and nine months ended September 30, 2021 the Company recognized share-based compensation expense of $ and $ and $ , respectively, related to common stock options. The Company expects to recognize additional compensation expenses of $4,669,160 related to these common stock options assuming all awards will vest.– $ , volatility between % - % based on peer companies, risk free interest rate between % - %, no dividends and an estimated life of years. During the three and nine months ended September 30, 2022, the Company recognized share-based compensation expenses of
Total stock-based compensation recorded for the three and nine months ended September 30, 2022 and 2021 for all stock based compensation awards, including warrants, has been recorded as follows:
The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).
Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef